who-istock-481275412

godfather744431 / iStockphoto.com

18 March 2019Americas

WHO and UN actions undermine IP and hurt innovation, warns PhRMA

Supranational organisations such as the World Health Organization (WHO) and the United Nations Development Program (UNDP) are promoting acts, policies and practices that prevent biopharmaceutical innovators from securing and maintaining patents.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

20 February 2018 Trade associations Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization have called for Malaysia to be placed on the US Trade Representative’s watch list in its “2018 Special 301 Report”.

PhRMA urges USTR to protect US innovation abroad

13 February 2017 The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.

More on this story

Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

20 February 2018 Trade associations Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization have called for Malaysia to be placed on the US Trade Representative’s watch list in its “2018 Special 301 Report”.

PhRMA urges USTR to protect US innovation abroad

13 February 2017 The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.

More on this story

Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

20 February 2018 Trade associations Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization have called for Malaysia to be placed on the US Trade Representative’s watch list in its “2018 Special 301 Report”.

PhRMA urges USTR to protect US innovation abroad

13 February 2017 The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent